Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Cyproheptadine Hydrochloride Tablets

Approval Number

国药准字H11021323

Company湖北荟海医药技术研究院有限公司

Registration Date

December 23, 2020

Previous Approval Numbers

国药准字H11021323

Drug Information

Generic Name

盐酸赛庚啶片

Brand Name

曙光

Dosage Form

片剂

Strength

按C21H21N·HCl计算2mg

Drug Type

化学药品

Registration Date

December 23, 2020

Company Information

Applicant Company

Company Name湖北荟海医药技术研究院有限公司

Company Address

湖北省咸宁市赤壁市高新区蛟龙桥路22号综合楼二楼、三楼、四楼

Manufacturing Company

Company Name北京曙光药业有限责任公司

Company Address

北京市朝阳区建国路管庄

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸赛庚啶片 - NMPA 批准文号 | MedPath